The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Acer Therapeutics Inc., a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-...
read more
Belite Bio, Inc, a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, such as ...
read more
Bayer announced that the FDA has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor ...
read more
Fresenius Kabi has introduced Bortezomib for Injection, a new generic equivalent to Velcade® in the U.S. and the newest addition to the most ...
read more
Worldwide Clinical Trials, Inc. a midsize, full-service contract research organization (CRO), announced that Rosemarie Corrigan has joined the company...
read more
Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced that the U.S. Food and Drug ...
read more
Vaxxinity, Inc. announced that UB-311, an anti-amyloid beta immunotherapeutic vaccine, has been granted Fast Track designation by the U.S. Food and ...
read more
Merck announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of microsatellite ...
read more
Prothena Corporation plc announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PRX012, a potential best-in...
read more
The University of Tokyo and Astellas Pharma Inc. have entered the second phase of their collaboration for co-creating innovative new medicines and ...
read more
Merck announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending...
read more
Wednesday, April 20, 2022
Arcturus Therapeutics Holdings Inc. announced topline data from an ongoing Phase 1/2/3 trial evaluating ARCT-154, Arcturus’ self-amplifying mRNA ...
read more
Hansa Biopharma AB, “announced the acceptance by the U.S. FDA of Hansa’s Investigational New Drug (IND) application to proceed with a Phase 3 study of...
read more
The FDA has published Manual of Policies and Procedures (MAPP) 5240.10, “Classifying Approved New Drug Products and Drug-Device Combination Products ...
read more
FDA is announcing the availability of a final guidance for industry entitled “Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment.”
read more